Core Insights - Jingtai Technology (02228.HK) and Baicheng Pharmaceutical (301096.SZ) have signed a cooperation intention agreement to collaborate on new drug development using AI and robotics [1] Group 1: Collaboration Details - Baicheng Pharmaceutical will commission Jingtai Technology to utilize its "AI + Robotics" platform for new drug research [1] - Jingtai Technology will delegate pharmaceutical research and other R&D tasks to Baicheng Pharmaceutical [1] Group 2: Research Focus Areas - The collaboration will target unmet clinical needs in various disease areas, including pain, hypersomnia, tumors, autoimmune diseases, and ophthalmology [1] - Both companies aim to advance the development and incubation of innovative drug pipelines through the AI drug development platform [1] Group 3: Future Plans - There are plans to establish a joint venture to explore broader commercial cooperation opportunities [1]
晶泰科技与百诚医药签订合作意向书 共同推进AI新药研发合作